Category: <span>News</span>

13th International Users’ Meeting 2022
Post

13th International Users’ Meeting 2022

We were pleased to have you at the 13th iVis International Users’ Meeting.
The Meeting was focused on the CIPTA® Web application with three dedicated sessions:
- Session 1: Principles, Definitions, Settings, and Web Communication protocol
- Session 2: Customized ray-tracing ablation plans for phakic and pseudo-phakic eyes
- Session 3: Preliminary Outcomes and Live Surgery

iRes™2 CE certification
Post

iRes™2 CE certification

We are pleased to announce the CE approval on iRes™2, our fastest 2.0Khz excimer laser, empowering the smallest 350um laser micro-spot to execute iVis proprietary full automated, real-time controlled, no-touch, cTen® surgical procedure, maximizing surgical performance and avoiding intra-operative risks.

CIPTA®2 CE certification
Post

CIPTA®2 CE certification

We are pleased to announce the CE approval on CIPTA®2, the unique cloud-based software conceived for interactive ray-tracing customized corneal surgical planning

SafeCross®+ CE certification
Post

SafeCross®+ CE certification

We are pleased to announce the achievement of the CE mark on SafeCross®+ medical device on May 7th, 2021.

SafeCross®+ is a riboflavin ophthalmic solution, patented by iVis Technologies, granting  high cross-linking efficiency in poor oxygen environment.